• Albemarle swung to third-quarter 2026 net income attributable to shareholders of $296.76 million from a year-earlier loss.
• Net sales rose 19% year over year to $1.55 billion, primarily due to higher Energy Storage and Specialties prices.
• Talison's Chemical Grade Plant 3 achieved 30 days of nameplate performance in September.
• Full-year 2026 capital expenditure expectations fell to $300 million–$350 million, reflecting capital efficiency improvements and resequenced early-stage projects.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Albemarle Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611041615PR_NEWS_USPR_____PH88312) on November 04, 2026, and is solely responsible for the information contained therein.